Neuropeptide S receptor ligands: a patent review (2005-2016)-Reference-Cited by-同舟云学术

Neuropeptide S receptor ligands: a patent review (2005-2016)

Published:2016-11-09 Issue:3 Volume:27 Page:347-362
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Ruzza Chiara¹,Calò Girolamo¹,Di Maro Salvatore²,Pacifico Salvatore³,Trapella Claudio³,Salvadori Severo³,Preti Delia³,Guerrini Remo³

Affiliation:

1. Department of Medical Sciences, Section of Pharmacology, School of Medicine and National Institute of Neuroscience, University of Ferrara, Ferrara, Italy

2. DiSTABiF, Second University of Naples, Caserta, Italy

3. Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2017.1254195

Reference80 articles.

1. Neuropeptide S

2. Phylogenetic appearance of neuropeptide S precursor proteins in tetrapods

3. Pharmacological Characterization of Human and Murine Neuropeptide S Receptor Variants

4. Human Neuropeptide S Receptor Is Activated via a Gαq Protein-biased Signaling Cascade by a Human Neuropeptide S Analog Lacking the C-terminal 10 Residues

5. A Novel Brain Penetrant NPS Receptor Antagonist, NCGC00185684, Blocks Alcohol-Induced ERK-Phosphorylation in the Central Amygdala and Decreases Operant Alcohol Self-Administration in Rats

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Market Potential and Prospects of Copper-based Pyridine Derivatives: A Review;Current Molecular Medicine;2023-07-26

2. Neuropeptide S Receptor as an Innovative Therapeutic Target for Parkinson Disease;Pharmaceuticals;2021-08-06

3. New quinolone derivatives as neuropeptide S receptor antagonists: Design, synthesis, homology modeling, dynamic simulations and modulation of Gq/Gs signaling pathways;Bioorganic Chemistry;2021-06

4. Pharmacology, Physiology and Genetics of the Neuropeptide S System;Pharmaceuticals;2021-04-23

5. Structure–Activity Relationship Studies on Oxazolo[3,4-a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent In Vivo Activity;Journal of Medicinal Chemistry;2021-03-18